These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 20619479)

  • 41. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
    [No Abstract]   [Full Text] [Related]  

  • 42. Limited predictive value of dual-time-point F-18 FDG PET/CT for evaluation of pathologic N1 status in NSCLC patients.
    Kim SJ; Kim YK; Kim IJ; Kim YD; Lee MK
    Clin Nucl Med; 2011 Jun; 36(6):434-9. PubMed ID: 21552019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
    Perigaud C; Bridji B; Roussel JC; Sagan C; Mugniot A; Duveau D; Baron O; Despins P
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):731-6. PubMed ID: 19632852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Shim YM; Yi CA; Kim HY; Chung MJ
    Cancer; 2007 Mar; 109(6):1068-77. PubMed ID: 17311309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
    Serra Fortuny M; Gallego M; Berna L; Montón C; Vigil L; Masdeu MJ; Fernández-Villar A; Botana MI; Cordovilla R; García-Luján R; Cases E; Monsó E
    BMC Pulm Med; 2016 Dec; 16(1):177. PubMed ID: 27931198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
    Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
    Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value on SUV-derived parameters assessed on
    Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
    BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X; Zhang H; Xing L; Ma H; Xie P; Zhang L; Xu X; Yue J; Sun X; Hu X; Chen M; Xu W; Chen L; Yu J
    Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
    Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
    Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
    Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
    Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.
    Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A
    Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT.
    Li S; Zheng Q; Ma Y; Wang Y; Feng Y; Zhao B; Yang Y
    PLoS One; 2013; 8(10):e78552. PubMed ID: 24205256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
    Saydam O; Gokce M; Kilicgun A; Tanriverdi O
    Med Oncol; 2012 Jun; 29(2):589-94. PubMed ID: 21380783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
    Shimizu K; Okita R; Saisho S; Yukawa T; Maeda A; Nojima Y; Nakata M
    Ann Nucl Med; 2015 Dec; 29(10):854-60. PubMed ID: 26254228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
    Onal C; Oymak E; Findikcioglu A; Reyhan M
    Int J Gynecol Cancer; 2013 Feb; 23(2):337-42. PubMed ID: 23358181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the
    Taira N; Atsumi E; Nakachi S; Takamatsu R; Yohena T; Kawasaki H; Kawabata T; Yoshimi N
    Lung Cancer; 2018 Sep; 123():30-35. PubMed ID: 30089592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.